( en | de | ru )

 

Disambiguation of "Lagier, Jean-Christophe"

Author of the publication

copydeleteadd this publication to your clipboard
Early Treatment with Hydroxychloroquine and Azithromycin in 10,429 COVID-19 Outpatients: A Monocentric Retrospective Cohort Study

, , , , , , , , , , , , , , , , , , , , , , , , , , , and . International Journal of Infectious Diseases, (2021)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Jean-Christophe Magnan

Jean-Christophe Legrix

Jean-Christophe Legrix

Jean-Christophe Roux

Jean-Christophe Nebel

 

Other publications of authors with the same name

Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID2 19 patients: a systematic review and meta-analysis, , , and . Clinical Microbiology and Infection, (2020)Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world, , , , , , , , , and 4 other author(s). New Microbes and New Infections, (2020)Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, , , , , , , , , and 33 other author(s). Travel Medicine and Infectious Disease, (2020)Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)Early treatment of 1061 COVID-19 patients with hydroxychloroquine and azithromycin, Marseille, France, , , , , , , , , and 27 other author(s). (2020)Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, , , , and . International Journal of Antimicrobial Agents, 55 (4): 105932 (2020)Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, , , , , , , , , and 8 other author(s). International Journal of Antimicrobial Agents, 56 (1): 105949 (2020)Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France, , , , , , , , , and 27 other author(s). Travel Medicine and Infectious Disease, (2020)Treatment of classic Whipple's disease: from in vitro results to clinical outcome, , , , , and . Journal of Antimicrobial Chemotherapy, 69 (1): 219–227 (2014)Early Treatment with Hydroxychloroquine and Azithromycin in 10,429 COVID-19 Outpatients: A Monocentric Retrospective Cohort Study, , , , , , , , , and 18 other author(s). International Journal of Infectious Diseases, (2021)